INOZYME PHARMA, INC. Total Liabilities
INOZYME PHARMA, INC. had Total Liabilities of $63.37 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-05-14
- 2025-03-31: Liabilities $63.37M.
- 2024-12-31: Liabilities $65.36M.
- 2024-09-30: Liabilities $60.57M.
- 2024-06-30: Liabilities $61.29M.
| Period end | Liabilities |
|---|---|
| 2025-03-31 | $63.37M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $65.36M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $60.57M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $61.29M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $58.11M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $60.37M 10-K · filed 2025-03-10 |
| 2023-09-30 | $45.49M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $45.34M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $38.45M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $20.80M 10-K · filed 2024-03-12 |
| 2022-09-30 | $19.24M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $12.81M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $14.70M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $14.27M 10-K · filed 2023-03-22 |
| 2021-09-30 | $11.77M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $9.98M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $10.03M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $11.26M 10-K · filed 2022-03-15 |
| 2020-09-30 | $11.08M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $6.96M 10-Q · filed 2020-09-03 |
| 2019-12-31 | $3.24M 10-K · filed 2021-03-25 |